| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 112.0 | 109.1 | 101.8 |
| Other income | 2.9 | 3.8 | 2.7 |
| Total income | 114.9 | 112.9 | 104.5 |
| Profit before exceptional items & tax | 27.5 | 28.3 | 26.3 |
| Profit before tax | 27.5 | 28.3 | 26.3 |
| Net profit | 20.6 | 21.0 | 19.9 |
| Operating margin | 23.9% | 25.1% | 25.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +3.50% |
|---|---|
| Net profit, quarter on quarter | -1.90% |
| Revenue, year on year | +10.00% |
| Operating profit, year on year | +4.20% |
| Operating profit, quarter on quarter | +0.40% |
BSE results filing, NSE: VIMTALABS. Figures extracted from the filing.
Vimta Labs Ltd: key numbers
- Share price
- ₹500.70
- Market cap
- ₹2,238 Cr
- Revenue (annual)
- ₹407.3 Cr
- Net profit (annual)
- ₹77.51 Cr
- P/E (TTM)
- 28.1×Sector 52.3×
- Promoter holding
- 35.64%-0.03% QoQ
- FII holding
- 5.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vimta Labs Ltd
All →Vimta Labs Results Update
Vimta Labs reported Q2 FY27 income of ₹1,149 Mn, up 9.9% YoY, and PAT of ₹206 Mn at 17.9% margin. EBITDA margins held steady at 35.5%.
Vimta Labs Investor Presentation: Key Takeaways
Q2 FY27: total income Rs1,149Mn (+9.9% YoY), EBITDA Rs408Mn (35.5% margin), PAT Rs206Mn (17.9% margin, +3.5% YoY). H1 FY27 PAT Rs417Mn (+7.3%).
Vimta Labs Board Meeting Date
Vimta Labs will hold a board meeting on 30 October 2026 to consider half-year results. Trading window stays closed from 01 October.
Vimta Labs Other Announcement
Vimta Labs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Vimta Labs Employee Stock Options
Vimta Labs allotted 12,955 ESOP shares under its 2021 plan. Paid-up capital rose to ₹8,93,99,718, raising dilution for shareholders.
Vimta Labs Credit Rating
CARE Ratings has reaffirmed the bank facility ratings of Vimta Labs Limited. The disclosure updates stakeholders on the company's ongoing credit facilities.